{"title":"In vitro-induced cancer-associated fibroblasts-derived Exosomal miRNA-224-5p targets PTEN to reduce cisplatin (DDP) sensitivity in colorectal cancer.","authors":"Xiao Wu, Pengcheng Ma, Ming Zhang, Ling Wang, Aijun Wang, Yuchuan Yan, Hongyu Wang, Chao Zhang, Junwei Feng","doi":"10.1093/intbio/zyaf022","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cancer-associated fibroblasts (CAFs)-derived exosomes promote tumor malignancy and confer chemotherapy resistance. However, their mechanistic roles in colorectal cancer (CRC) remain incompletely understood.</p><p><strong>Methods: </strong>Human normal colon fibroblasts were induced into CAFs using CRC cell-conditioned medium and identified by immunofluorescence. Exosomes were isolated from CAFs and characterized by Western blot, DLS analysis and cell uptake experiment. qPCR was employed to detect miRNA-224-5p expression in CAFs-derived exosomes. CCK-8 and comet assays were conducted to evaluate miRNA-224-5p's effect on cisplatin (DDP) resistance in CRC. TargetScan predicted miRNA-224-5p's downstream targets, with luciferase assays validating its interaction with PTEN. Overexpression experiments elucidated miRNA-224-5p's mechanism in DDP resistance via PTEN regulation.</p><p><strong>Results: </strong>miRNA-224-5p was highly expressed in CAFs-derived exosomes. Functional assays revealed that exosomal miRNA-224-5p from CAFs promoted DDP resistance in CRC cells while suppressing DNA damage and apoptosis. Mechanistically, PTEN was identified as a direct target of miRNA-224-5p, through which it enhanced DDP resistance.</p><p><strong>Conclusion: </strong>This study demonstrates that CAFs-derived exosomal miRNA-224-5p promotes DDP resistance in CRC by targeting PTEN, suggesting miRNA-224-5p as a potential therapeutic target for improving CRC treatment outcomes. Insight box MiRNA-224-5p was highly expressed in CAFs-derived exosomes. Functional assays revealed that exosomal miRNA-224-5p from CAFs promoted DDP resistance in CRC cells while suppressing DNA damage and apoptosis. PTEN was identified as a direct target of miRNA-224-5p, through which it enhanced DDP resistance.</p>","PeriodicalId":520649,"journal":{"name":"Integrative biology : quantitative biosciences from nano to macro","volume":"17 ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrative biology : quantitative biosciences from nano to macro","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/intbio/zyaf022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Cancer-associated fibroblasts (CAFs)-derived exosomes promote tumor malignancy and confer chemotherapy resistance. However, their mechanistic roles in colorectal cancer (CRC) remain incompletely understood.
Methods: Human normal colon fibroblasts were induced into CAFs using CRC cell-conditioned medium and identified by immunofluorescence. Exosomes were isolated from CAFs and characterized by Western blot, DLS analysis and cell uptake experiment. qPCR was employed to detect miRNA-224-5p expression in CAFs-derived exosomes. CCK-8 and comet assays were conducted to evaluate miRNA-224-5p's effect on cisplatin (DDP) resistance in CRC. TargetScan predicted miRNA-224-5p's downstream targets, with luciferase assays validating its interaction with PTEN. Overexpression experiments elucidated miRNA-224-5p's mechanism in DDP resistance via PTEN regulation.
Results: miRNA-224-5p was highly expressed in CAFs-derived exosomes. Functional assays revealed that exosomal miRNA-224-5p from CAFs promoted DDP resistance in CRC cells while suppressing DNA damage and apoptosis. Mechanistically, PTEN was identified as a direct target of miRNA-224-5p, through which it enhanced DDP resistance.
Conclusion: This study demonstrates that CAFs-derived exosomal miRNA-224-5p promotes DDP resistance in CRC by targeting PTEN, suggesting miRNA-224-5p as a potential therapeutic target for improving CRC treatment outcomes. Insight box MiRNA-224-5p was highly expressed in CAFs-derived exosomes. Functional assays revealed that exosomal miRNA-224-5p from CAFs promoted DDP resistance in CRC cells while suppressing DNA damage and apoptosis. PTEN was identified as a direct target of miRNA-224-5p, through which it enhanced DDP resistance.